TrialClinical cancer research : an official journal of the American Association for Cancer Research2020

Outcome-Related Signatures Identified by Whole Transcriptome Sequencing of Resectable Stage III/IV Melanoma Evaluated after Starting Hu14.18-IL2.

Richard K Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.